Psychotic symptoms in subjects with Alzheimer disease (AD with psychosis, AD þ P) define a phenotype characterized by greater cognitive burden than in AD without psychosis. We have proposed that genes of small effect may contribute to the risk for expression of psychosis in multiple disorders, including AD. Recently, sex-differential association of a three-locus haplotype, including a G-A transition at codon 108/158 of catechol-O-methyltransferase (COMT) resulting in a Val-Met substitution, has been reported to confer an increased risk for schizophrenia. The main objective of the study was to determine if COMT genetic variation is associated with risk of psychosis in AD, and included a case-control study of 373 individuals diagnosed with AD with, or without, psychosis. All subjects were characterized for alleles at the three loci associated with schizophrenia, RS737865, COMT G-A 108/158 (RS4680), and RS165599, and for a C/T transition adjacent to an estrogen response element (ERE6) in the COMT P2 promoter region. Both single locus and haplotype tests of association were conducted. Logit models were used to examine independent and interacting effects of alleles at the associated loci. All analyses were stratified by sex. In female subjects, RS4680 demonstrated a modest association with AD þ P; RS737865 demonstrated a trend towards an association. There was a highly significant association of AD þ P with the four-locus haplotype, which resulted from additive effects of alleles at RS4680 and ERE6 (or RS737865, as this locus was in almost absolute linkage disequilibrium (LD) with ERE6). In male subjects, no single locus test was significant, but there remained a strong association between AD þ P and the four-locus haplotype. This association appeared to result from interaction of the ERE6/ RS737865, RS4680, and RS165599 loci. Genetic variation in COMT is associated with AD þ P, and thus appears to contribute to psychosis risk across disorders. Sex-differential associations of COMT with psychosis may result from variation at, or in LD with, ERE6. Examination of variation at ERE6 in subjects with schizophrenia, and further examination of the independent and additive effects of variations in COMT on gene expression, is warranted.
While much about the genetic etiology of Alzheimer disease (AD) remains unknown, significant strides have been made. The genetic basis of some early onset subtypes, a minority of the population of AD cases, has been determined. Aside from the pivotal role of ApoE, the genetic architecture of the more common late onset AD is less clear. One means of furthering our understanding of the genetic architecture of late onset AD is to seek more etiologically homogeneous phenotypes from which to identify new risk alleles.
For late age onset of AD, we have previously proposed that the presence of psychotic symptoms (AD with psychosis, AD þ P) identifies one such phenotype. 1 AD þ P occurs in approximately 30-60% of individuals with AD. 1 The AD þ P phenotype is familial, 2 with an estimated heritability of 61-70%. 3 AD þ P demonstrates linkage to specific chromosomal regions, 4, 5 is associated with variation in biologically plausible candidate genes, [5] [6] [7] [8] and is characterized by distinct post-mortem neurochemical changes. 9 Clinically, the course of AD þ P, in comparison to the course of AD without psychosis, is characterized by more severe cognitive impairment, more rapid cognitive decline, more rapid functional decline, and premature institutionalization. [10] [11] [12] [13] [14] Guided by the recognition that some of the reported genetic associations, regions of linkage, post-mortem neurochemical changes, and clinical features of AD þ P overlap with those identified in schizophrenia, we have proposed a genetic model in which disease-modifying genes of small individual effect might contribute to the liability to psychosis across disorders. 1 Recently, the association between schizophrenia and the catechol-O-methyltransferase gene (COMT) has been explored extensively. COMT is located on chromosome 22q11.2, proximate or within the site of microdeletions found in patients with Velocardiofacial syndrome, a disorder in which up to 30% of sufferers have schizophrenia. [15] [16] [17] [18] In addition, COMT is a functional candidate gene for schizophrenia and other psychotic disorders because it encodes a protein that enzymatically inactivates dopamine among other catecholamine neurotransmitters. 19 The most frequently examined COMT polymorphism in subjects with schizophrenia has been a G-A substitution at codon 108/158 of COMT resulting in a Val-Met substitution. When the activity of COMT enzyme encoded by these variants was studied in human blood and liver cells, the more heat-stable valine variant encoded by the G allele is characterized by a three-to four-fold higher activity. 20 A recent meta-analysis reviewed 14 case-control and five family studies of the G-A 108/158 polymorphism in schizophrenia. 21 They concluded there was sufficient evidence to indicate a minor increase in risk for schizophrenia associated with the Val (G) allele in Caucasian populations.
Shifman et al 22 recently proposed that the association between the COMT G-A 108/158 polymorphism (henceforth RS4680) and schizophrenia may result from a true association of schizophrenia with alleles in close proximity to those at RS4680 (Figure 1 ). They found evidence for a strong association between haplotype and schizophrenia in a large case-control analysis of Ashkenazi Jews. Through examining 12 SNPs in COMT, they found the RS737865-RS4680-RS165599 haplotype to be strongly associated with schizophrenia. Of interest, the three loci demonstrated sex-specific associations with schizophrenia. 22 Recently, a C/T polymorphism adjacent to an estrogen response element (ERE) has been reported in COMT. EREs have been found in the promoter regions of many genes, and they are involved in the regulation of transcription. 23 It was proposed that this mechanism could account for the observation of sexually dimorphic COMT activity. 24 Although the effect of estrogen on COMT, mediated by several of these elements, is to downregulate the expression of COMT, estrogen receptor binding to this specific ERE, ERE6, has been shown to increase expression. 24 Thus, ERE6 could play a role in the sex-differential effects of COMT alleles and haplotypes on liability to schizophrenia recently reported. 22 We therefore examined the association between AD þ P and four polymorphisms, RS4680, ERE6, RS737865, and RS165599, as single loci and multilocus haplotypes. To account for possible sex-differential associations, we stratified analyses by gender.
Methods

Subjects
All patients were examined at the Geriatric Psychiatry Inpatient Program and the Alzheimer Disease Research Center (ADRC) of the University of Pittsburgh Medical Center, Pittsburgh, PA, between 1986 and 2002. Subjects underwent an extensive diagnostic and behavioral assessment, which has been described in detail elsewhere, 6, [25] [26] [27] [28] and received a diagnosis of possible or probable AD utilizing the National Institute of Neurologic and Communicative Disorders and Stroke-Alzheimer Disease and Related Disorders Association criteria. 29 The rate of autopsy confirmation of AD in subjects diagnosed with possible and probable AD exceeds 90% in our center. 25, 26 Assessment of psychosis was performed using the Empirical Behavioral Pathology in Alzheimer Disease scale (E-BEHAVE-AD) 30 for patients from the Geriatric Psychiatry Inpatient Program, and the Behavior Rating Scale for Dementia of the Consortium to Establish a Registry for Alzheimer Disease for subjects at the ADRC. 31 Psychosis was defined by the presence of persistent hallucinations or delusions occurring at any time during the course of the dementia. 6, 27, 28 The 313 subjects evaluated at the ADRC and rated on the Behavior Rating Scale for Dementia were also classi- fied into Paranoid and Misidentification subgroups as previously described. 28, 32 All data collected in this study were obtained with protocols approved by the Institutional Review Board of the University of Pittsburgh.
Genotyping DNA was extracted from whole blood using the phenol chloroform method. A T/C polymorphism adjacent to ERE6 upstream of the COMT start site was first described by Kinnear et 
Statistical analysis
Logit models were used to relate behavioral phenotypes to COMT genotypes by assuming a linear relationship, on the logit scale, between risk of AD þ P frequency and the number of minor alleles in the genotype. The program eHap 35 was used to estimate haplotype frequencies and relate haplotypes to phenotypes by using likelihood techniques that account for haplotype uncertainty. The program offers a flexible set of hypothesis tests, including goodnessof-fit or omnibus tests and specified contrasts of association between haplotypes and phenotypes (in this case risk of psychosis). As described in Seltman et al, 35 a default way to determine these contrasts is to use inferred evolutionary relationships among haplotypes to structure the tests of association, a method originally proposed by Templeton et al [36] [37] [38] [39] and used in a variety of settings. [40] [41] [42] Instead, we structured the tests to produce salient contrasts of haplotypes bearing the RS4680 A/G and ERE6 C/T alleles (see below).
Results
Of the 373 individuals who participated in this study ( Since Shifman et al 22 detected differences between male and female control individuals in the RS165599 genotype distributions, we also tested for such differences in the AD subjects without psychosis. We found no significant differences in allele or genotype frequencies between male and female subjects for any of the four loci (all P40.1). The number of non-EA subjects in our sample (Table 1) is small for meaningful comparison of the EA vs non-EA populations. Nonetheless, the distributions of alleles at these loci in our samples of EA (Table 2 ) and non-EA ancestry (data not shown) suggest substantial differences at ERE6 and RS737856 (two-tailed Fisher Exact Test, P ¼ 0.0092 and 0.0075, respectively), some differentiation at RS165599 (Fisher Exact Test, P ¼ 0.051), and none at RS4680 (Fisher Exact Test, 0.701). This differentiation complicates interpretation of analyses combining both samples and the limited number of non-EA subjects precludes estimation of association for the non-EA sample. Thus, all our analyses use only the EA data.
Across the four groups formed by gender and presence/absence of psychosis, the distributions of genotypes showed more heterogeneity for RS4680 than for the other loci (Table 2) . On the logit scale, the 
risk of psychosis increased significantly with the number of G alleles for female subjects, but no such effect was seen in male subjects (Table 3) . RS737865 also showed weak evidence for association between alleles and AD þ P in female subjects (Table 3) . Alleles at all four loci, at least when taken individually, appeared to have no impact on the risk of AD þ P for male subjects ( Table 3) . As recent literature suggests, 22 it is conceivable that alleles at multiple loci have a more salient effect on risk for AD þ P than do alleles at individual loci. To evaluate such effects, we first estimated the frequencies of the four-locus haplotypes in men and women with and without psychosis ( Table 4 ). The most common haplotype in these samples was C-A-A-T, accounting for about 35% of all haplotypes (alleles are listed in the order the loci occur on the chromosome:
ERE6-RS737865-RS4680-RS165599). Of the 16 haplotypes that could be produced by these loci, all but two appeared to be present in at least one sample (Table 4) ; of those missing, C-G-A-C was present but rare in the non-EA samples. In addition to the two missing haplotypes, seven others appear to be rare in these samples (Table 4) .
For analytic purposes, we chose to lump rare haplotypes together with more common haplotypes on the basis of similarity. 43 Ideally, for example, haplotypes separated by one-step mutations would be grouped; however, it was apparent (Figure 2a ) that the one-step relationships among haplotypes were too complicated for this simple rule of clustering. In fact, using this and other standard evolutionary assumptions 44 to simplify the network distributes the functional Val-Met polymorphism of RS4680 haphazardly in the unrooted tree (data not shown), a result that is counterintuitive from the analytical perspective. Instead, we chose to group first according to alleles with known functional effects at RS4680, and then those with hypothesized functional effects at ERE6.
This simplified the complex network ( Figure 2a ) into a manageable tree (Figure 2b ). We used this tree to produce structured contrasts of whether similar haplotypes had similar risks to AD þ P, using the methods in Seltman et al. 35 In that approach, the outer nodes of the tree (eg, 15) were contrasted with connected inner nodes (eg, 16). If the nodes had indistinguishable risk for AD þ P, as determined by a Bonferroni-corrected significance test, they were assumed to have common risk; then, the common risk estimated for these nodes (eg, 15 and 16) was contrasted to the linked inner node (in this case 10, and possibly 9, if risk associated with 9 and 10 were indistinguishable). If no significant contrasts were present, then the tree 'collapses' to a point, suggesting independence between haplotypes and risk of AD þ P.
For female subjects, the tree reduced to three major nodes ( Figure 2c ). As expected, on the basis of the results from the logit model, the haplotype-based analyses revealed a major difference between haplotypes carrying the G vs A allele at RS4680 (haplotype groups 9 and 10 vs 1, 2, and 8). However, the analyses also indicated that haplotypes carrying the C allele at ERE6, as well as the G allele at RS4680 (C-G) had significantly higher risk than the T-G haplotype at these loci (haplotype groups 9 and 10 vs 15 and 16). Notice, however, that the contrast completely confounded the alleles at ERE6 and RS737865; it was not possible to distinguish between the contribution to risk of the C allele at ERE6 and the A allele at RS737865. Supporting the tree-based contrasts, when overall independence of haplotypes and psychosis Arguably the best summary of psychosis risk for female subjects for these loci was the additive impact of risk alleles at RS4680 and ERE6 (or RS737865, see below). In fact, there was a strong linear relationship between number of ERE6 C and RS4680 G alleles and the risk for AD þ P in female subjects (Figure 3) . Similarly, by exploration of logit models, a model in which additive effects (on the logit scale) of the alleles at RS4680 and ERE6 conferred risk appeared to explain the data for female subjects best, with each locus contributing roughly equally to risk (RS4680: slope ¼ 0.7905, P ¼ 0.0007; ERE6: slope ¼ 0.6720, P ¼ 0.0032).
Based on the results of the single locus logit analyses, one might have predicted that there would be no significant contrasts for the samples from male subjects. That expectation was not realized, however; instead, the contrasts revealed substantial complexity (Figure 2d) , as suggested by the estimated haplotype distributions ( Table 4 ). The principle feature of the final tree was the limited set of 'collapses', which could indicate that haplotypes differed substantially in their effect on risk for AD þ P. Hidden from view was the fact that two of the three contrasts producing 'collapses' (2 vs 1 and 2/1 vs 9/10) were significantly different at the 0.05 level but not at the Bonferronicorrected level, 0.05/6 ¼ 0.0083. These results suggest that alleles at all four loci, or more likely three loci as described below, interacted to confer risk. A test of overall independence of haplotypes and psychosis status was also rejected (w 2 ¼ 30.1; DF ¼ 6; Po0.0005).
Indeed, in a logit model specifying a three-way interaction of loci RS4680, ERE6, and RS165599, the three-way interaction was close to significant (P ¼ 0.08). And unlike the data for female subjects, no simple, parsimonious logit model could be found that predicted psychosis risk, perhaps because the data for male subjects was sparser. In our explorations, two models appeared almost equally viable: the three-way interaction model just described, and a model containing the three-way interaction, main effects of RS4680 and ERE6, their interaction, and the interaction of RS4680 and RS165599. Neither of these models fit data for females adequately-although the signs of the slopes for each effect were the same in male and female subjects.
Complicating interpretation of some of the results was confounding between alleles at ERE6 and RS737865. When pairwise linkage disequilibrium (LD) was measured for these loci, ERE6 and RS737865 were found to be in almost absolute LD (Table 5 ): the C allele at ERE6 was almost always found with the A allele at RS737865. Therefore, it is unsurprising that the effects of these loci on psychosis risk were indistinguishable. No other pair of loci demonstrated such a substantial level of LD (Table 5 ).
Discussion
Our results reveal an association between genetic variation in COMT and the presence of psychotic symptoms in female and male subjects with AD, although the nature of the association varies by sex. For single-locus analyses and data on female subjects with AD, RS4680, a G-A substitution at codon 108/ 158 of COMT resulting in a Val-Met substitution, demonstrated a modest association with increased risk of psychosis in our subjects with AD. One other locus, RS737865, demonstrated a trend towards such an association. Overall, there was a highly significant association of the four-locus haplotype with AD þ P in female subjects, which appeared to result from additive effects of alleles at ERE6/RS737865 (these two loci were in very high LD, so it was impossible with our data to separate the effects of the individual loci) and at RS4680.
The results for male subjects were much more complex. The data suggest that haplotypes differed substantially in their impact on liability, and that a three-way interaction of COMT alleles might be required to determine risk for AD þ P in male subjects. The smaller number of male subjects in our cohort limits this interpretation. Final resolution of models for the risk of psychosis in male AD subjects involving COMT loci will likely require additional data sets.
There are potential limitations to our study. The subjects were enrolled from a geriatric psychiatry inpatient unit and an Alzheimer Disease Research Table 4 . Connecting lines indicate haplotypes separated by onestep mutations; (b) unrooted tree obtained by grouping rare haplotypes with common haplotypes. Haplotypes were grouped first according to alleles at RS4680, then at ERE6, resulting in seven groups. Each group is denoted in the tree by the number of the common haplotype in the group. Haplotype group 1 includes haplotypes 1 and 3; group 2 includes 2, 4, and 6; group 8 includes 7 and 8; group 9 includes 9 and 13; group 10 includes 10, 11, 12, and 14. Notice, by construction, that a line dividing haplotype groups 2 and 10 splits the tree by alleles at RS4680, and that thin lines connect haplotypes separated by more than one-step mutation; (c) tree resulting from the analysis of the data from female subjects with AD, in which separate nodes represent one or more haplotype groups that confer significantly different risk for AD þ P. Thick lines indicate that at least one of the connected haplotype groups are separated by one-step mutations, thin lines indicate that all of the connected haplotype groups are separated by more than one-step mutation; (d) tree resulting from the analysis of data from male subjects with AD, conventions are the same as in (c).
Number of Risk (C or G) Alleles Center, and are therefore unlikely to be representative of the general population of elderly subjects with AD. Subjects had not necessarily traversed the complete course of AD. It is likely that some subjects, currently classified as without psychosis, would have developed AD þ P later in their illness. Presumably, the effect of such a bias would have been to reduce the observed association in the current sample. Our analyses were restricted to EA subjects, and thus may not generalize to individuals of other ethnic origins. Case-control studies of genetic association, while offering enhanced power, may be prone to false positive associations due to population stratification. While a number of genome scans of AD have been reported, [45] [46] [47] [48] including one small study of AD þ P, 4 significant or suggestive linkage to chromosome 22q, where COMT is located, has not been reported. The absence of prior evidence of linkage to chromosome 22q does not exclude the possibility of association of COMT with AD þ P. We are aware of one other casecontrol study that has also found a significant association of RS4680 G alleles with psychosis risk in AD, although other SNPs were not studied. 49 Regardless, confirmation of the associations of COMT with AD þ P in other studies, especially family-based studies, would still be appropriate. False positive associations can also result from multiple comparisons. Correcting for multiple testing in the current analysis would change the minimal significance level of the single locus tests, although tests of haplotype associations would remain robustly significant. Finally, we analyzed the data by sex because prior literature had suggested sex-differential expression of COMT and association of COMT loci. Without the a priori information, however, sex dependence may have been missed because the power to detect the three-way interaction, sex by genotype by psychosis status, is limited in our data. It remains controversial whether the association between psychosis and COMT genotype is mediated by RS4680 itself. 50 ,51 RS4680 G alleles encode a valine at position 158 of membrane-bound COMT (108 of soluble COMT). It has been known that the valinecontaining variant of soluble COMT has higher activity, 20 and recently it has been demonstrated that the valine variant is similarly associated with increased COMT protein and increased COMT enzyme activity in prefrontal cortex of post-mortem human brain from normal subjects. 52 COMT mRNA expression has been examined in prefrontal cortex of subjects with schizophrenia, without evidence of any global change in the level of transcription. 53, 54 However, a more subtle laminar change in COMT mRNA expression was present in the subjects with schizophrenia, with downregulated expression in superficial cortical layers and upregulated expression in middle and deep layers. 53 This pattern did not associate with RS4680 genotype. 53 We are not aware of studies in subjects with schizophrenia evaluating cortical COMT protein levels or activity, or of studies examining COMT mRNA expression in other brain regions where it may exert pathogenic effects in subjects with schizophrenia.
Alternatively, Shifman et al 22 recently reported that the association between COMT and schizophrenia may be due to a highly significant association with a three-locus haplotype including RS737865, RS4680, and RS165599. Support for association of this threelocus haplotype with schizophrenia is found in two recent studies using family-based designs, although the alleles associated with increased risk at the loci differed. 51, 55 Variations at all three loci (RS737865, RS4680, and RS165599) result in allele-specific reductions of the membrane-bound COMT transcript of moderate magnitude (13-22%). 50 Of particular interest, in view of the current findings, Shifman et al 22 identified sex-differential effects, with RS737865 associated in both sexes, RS4680 associated in male subjects, and RS165599 associated in female subjects. The finding of sex-differential effects was confirmed in the one family-based study to examine the question, although in this study RS737865 was associated with increased risk in female subjects, while RS4680 and RS165599 had effects primarily in male subjects. 51 Although sample sizes were limited, the reported allele-specific reduction in COMT mRNA expression associated with RS737865, RS4680, and RS165599 did not differ by sex. 50 COMT activity in prefrontal cortex, however, did show sex effects paralleling those in the periphery (lower activity in female subjects). 52 There was not a sex by genotype interaction in the prefrontal cortex, although such an interaction was present when assaying COMT in lymphocytes, resulting from a more pronounced effect of RS4680 genotype in male subjects. 52 Our data, albeit obtained in psychosis associated with AD, confirm and potentially extend these prior findings in several key ways. We similarly found a sex-differential association of psychosis with the three-locus haplotype defined by RS737865, RS4680, and RS165599. However, RS737865 was in nearly absolute LD in our sample with a polymorphism located in the P2 promoter, adjacent to an ERE, ERE6. Since ERE6 is positioned to impact on the expression of COMT, and contribute to sex-specific differences through estrogen binding, we suspect effects were due to the ERE6 polymorphism. However, a straightforward way to assess their effects would be by promoter assays of the alleles at these loci. Surprisingly, we are not aware of such assessments of the COMT variants implicated in psychosis, although such assays have demonstrated the role of EREs in controlling COMT expression, and the distinct role of ERE6 in particular as the only COMT ERE that upregulates COMT expression. 24 Whether a similar degree of LD exists between ERE6 and RS737865 in the populations in which haplotype associations with schizophrenia have been reported is not known, 22, 51, 55 although LD in this region varies between populations of origin that contribute to our subject pool. 56 Regardless of which locus affects expression, the data suggest that the joint action of alleles at RS4680 and ERE6/RS737865 have a strong impact on risk for AD þ P (Figures 2 and 3) , and raise the possibility that variation at ERE6 may impact the risk for schizophrenia or other psychosis in a sexspecific manner. As alleles at RS4680 influence estrogen metabolism, 57 sex-specific effects may also result from variation at this locus, and from interactions between RS4680 and ERE6.
Furthermore, our data provide some guidance with regard to the nature of the interactions of the ERE6/ RS737865, RS4680, and RS165599 loci. We found evidence of independent additive effects of alleles at ERE6/RS737865 and RS4680 on AD þ P risk in female subjects. This result is highly congruent with the one other study to examine potential interactive effects of variation at these loci, which found that RS737865 had independent effects which moderated the effects of variation at RS4680 and RS165599, and that the effect of RS737865 was more pronounced in female subjects. 51 In male subjects, the association was explained comparably by either of the two competing logit models: a three-way interaction of alleles at ERE6/RS737865, RS4680, and RS165599; or a model containing the three way interaction, main effects of RS4680 and ERE6, their interaction, and the interaction of RS4680 and RS165599. Clearly the haplotypes differed substantially in their impact on liability in male subjects. These results could arise, however, either because alleles at these loci physically interact in some manner to alter gene expression and/or protein translation, or because allelic variation at other coding or regulatory sequences in COMT that yield psychosis risk occur at differing rates on the haplotype backgrounds defined by the loci we evaluated. How altered expression and/or activity of COMT might contribute to psychosis risk is an important question. Several studies have found an association between the RS4680 Val (G) allele and impairments of cognitive function in subjects with schizophrenia. 58, 59 Overall, however, genotype only explained a minority of the variance in cognitive performance. 58, 59 Importantly, the relationship between the Val (G) allele and cognitive impairment was present not only in subjects with schizophrenia but also in their unaffected siblings and in unaffected unrelated controls. 58 These findings would be consistent with RS4680 providing a minor contribution to psychosis risk by acting through a cognitive risk phenotype.
Although the nature and frequency of specific psychotic symptoms in AD differs from schizophrenia, 1, 60 psychosis in AD also confers cognitive dysfunction. A number of studies have found that AD þ P subjects, in comparison to AD subjects without psychosis, demonstrate more severe cognitive and functional deficits, [61] [62] [63] [64] and more rapid cognitive decline. 10, [12] [13] [14] 65 Thus, in AD, psychosis presence is a marker for a cognitive risk phenotype. AD þ P, however, may itself be a composite of distinct phenotypes. Using factor and cluster analyses, we recently proposed that AD þ P can be subdivided into Paranoid and Misidentification groups. 28 Of interest, the association between more severe cognitive impairment and AD þ P appears to be mediated by the Misidentification group. 32 In comparison to AD subjects without psychosis, Paranoid AD þ P subjects show no additional cognitive deficits. In contrast, Misidentification AD þ P subjects demonstrate more severe disruption of frontotemporal function. 32 Thus, if the observed association between risk of AD þ P and COMT alleles results from a cognitive risk phenotype, it would be anticipated that variation in COMT would be associated with the Misidentification, but not the Paranoid, subtype of AD þ P. We examined this in an exploratory manner, due to limited sample size in the subgroups, restricting analysis to female subjects and the ERE6 and RS4680 loci that contributed to psychosis risk. The 208 female subjects evaluated at the ADRC and rated on the Behavior Rating Scale for Dementia could be classified into Paranoid (N ¼ 45 (21.6%) ). Misidenti-fication (N ¼ 60 (28.8%)), and nonpsychotic subgroups as previously described. 28, 32 The female Misidentification group showed a significantly different ERE6 genotype distribution in comparison to the female AD subjects without psychosis (w 2 2 ¼ 6.23, P ¼ 0.044; w 1 2 ¼ 4.21, P ¼ 0.040). In addition, the RS4680 genotype distributions for the female Misidentification group vs the female AD subjects without psychosis were marginally differentiated (w 2 2 ¼ 4.87, P ¼ 0.087; w 1 2 ¼ 3.13, P ¼ 0.077), and Misidentification was significantly associated with an increased frequency of the C-G two-locus haplotype (permutation test P ¼ 0.026). For women classified in the Paranoid group, there were no significant associations for individual loci or haplotypes. The finding that COMT genotype was associated with Misidentification, but not Paranoid female subjects, is congruent with a contribution of COMT to AD þ P risk via a cognitive risk phenotype. Clearly this requires replication in a larger sample including men, with the examination of additional haplotype associations, and direct tests of whether the association between COMT and Misidentification is mediated by an effect of variation at COMT on specific neuropsychologic domains.
We have previously proposed that psychosis liability in AD might be mediated by genes that contribute to psychosis risk across disorders. 1, 6 The observation of an association of COMT haplotype with AD þ P is consistent with the hypothesis that COMT is one such gene, as is a recent report of an association of COMT haplotype with risk for Bipolar disorder. 66 Independent confirmation of the association of AD þ P with COMT haplotype, including confirmation in familybased designs, is needed. Examination of the association of variation at ERE6 in subjects with schizophrenia, and further examination of the independent and additive effects of variations in COMT on gene expression, is warranted.
